Published animal experiments showed that TGP could regulate skin inflammation in psoriasis-like mouse models and is induced by imiquimod by activating psoriatic dermal mesenchymal stem cells and modulating vascular endothelial growth factor (VEGF) expression (Lei et al., 2023; Zhang et al., 2021). The gene discussed is TGM4; the disease is psoriasis.